Korean J Ophthalmol.  2006 Mar;20(1):7-12. 10.3341/kjo.2006.20.1.7.

The Clinical Characteristics and Treatment Results of Ocular Adnexal Lymphoma

• Woo JM
• Tang CK
• Rho MS
• Lee JH
• Kwon HC
• Ahn HB

• KMID: 1099066
• DOI: http://doi.org/10.3341/kjo.2006.20.1.7

Abstract

PURPOSE: To assess the clinical pattern, the histopathological findings, the response to treatments, the recurrence pattern and the prognosis of malignant lymphoma in the ocular adnexa. METHODS: This study was performed on 22 total eyes from 17 patients who were diagnosed with ocular adnexal malignant lymphoma. We retrospectively analyzed the medical records for patient information including the histological classification based on age, the gender of each patient, the symptoms and signs at the initial diagnosis, the presence of binocular invasion, the findings of the surgical biopsy, the clinical stage of each patient's tumor, and the treatment methods used and their effectiveness. The mean follow-up period was 24.8 months. RESULTS: The mean age of patients studied was 46.8 years old. Six females and 11 males were included in the study. Fifteen cases consisting of 20 total eyes represented extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue (MALT). Five of seven patients (71.4%) whose lymphoma occurred within the conjunctiva relapsed after irradiation or chemotherapy, and four of the relapsed patients were salvaged with further therapy. CONCLUSIONS: Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue (MALT) constituted 88.2% of all lymphomas involving the ocular adnexa. Lymphoma in the ocular adnexa responded well to conventional treatment, but the recurrence rate of lymphoma in the conjunctiva was significantly high.

Keyword

Extranodal marginal zone B cell lymphoma; Ocular adnexal lymphoma

MeSH Terms

Treatment Outcome
Retrospective Studies
Neoplasm Recurrence, Local
Middle Aged
Male
Lymphoma, Mucosa-Associated Lymphoid Tissue/drug therapy/*pathology/radiotherapy/surgery/*therapy
Humans
Follow-Up Studies
Female
Eye Neoplasms/drug therapy/*pathology/radiotherapy/surgery/*therapy
Combined Modality Therapy
Biopsy
Aged, 80 and over
Aged
Adult

Reference

1. Dunbar SF, Linggood RM, Doppke KP, et al. Conjunctival lymphoma: results and treatment with a single anterior election field. A lens sparing approach. Int J Radiant Oncol Biol Phys. 1990; 19:249–257.

2. The Hematolymphoreticular Study Group of the Korean Society of Pathologist. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Cancer. 1998; 83:806–812. PMID: 9708949.

3. Witherspoon AC, Diss TC, Pan L, et al. Primary low-grade B-cell lymphoma of the conjunctiva: a mucosa-associated lymphoid tissue type lymphoma. Histopathology. 1996; 28:129–134. PMID: 8834520.

4. Shirai K, Okada Y, Saika S, Ohnishi Y. A case of mucosaassociated lymphoid tissue (MALT) lymphoma of presumed lacrimal gland origin. Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol). 1996; 90:604–606.

5. Coupland SE, Krause L, Delecuse HJ, et al. Lymphoproliferative lesions of the ocular adrexa: analysis of 112 cases. Ophthalmology. 1998; 105:1430–1441. PMID: 9709754.

6. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic disease of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie house, Virginia, November 1997. Histopathology. 2000; 36:69–87. PMID: 10632755.

7. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasm: a proposal from the international lymphoma study group. Blood. 1994; 84:1361–1392. PMID: 8068936.

8. Ellis JH, Banks PM, Campbell RJ, Liesegang TJ. Lymphoid tumors of the ocular adnexa. Clinical correlation with the working formulation classification and immunoperoxidase staining of paraffin sections. Ophthalmology. 1985; 92:1311–1324. PMID: 3906488.

9. White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adrexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology. 1995; 102:1994–2006. PMID: 9098307.

10. Erkal HS, Serin M, Sak SD, Cakmak A. Radiation therapy for stage I primary orbital non-Hodgkin's lymphomas. Tumori. 1997; 83:822–825. PMID: 9428915.

11. Stafford SL, Kozelsky TF, Garrity JA, et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol. 2001; 59:139–144. PMID: 11325441.

12. Pelloski CE, Wilder RB, Ha CS, et al. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol. 2001; 59:145–151. PMID: 11325442.

13. Bolek TW, Moyses HM, Marcus RB Jr, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys. 1999; 44:31–36. PMID: 10219791.

14. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol. 2005; 49:49–55. PMID: 15692775.

15. Jenkins C, Rose GE, Bunce C, et al. Histological features of adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 2000; 84:907–913. PMID: 10906102.

16. Rosenberg SA, Boiron M, DeVita VT Jr, et al. Report of the Committee on Hodgkin's Disease Staging Procedure. Cancer Res. 1971; 31:1862–1863. PMID: 5121695.

17. Kim YH, Fayos JV. Primary orbital lymphoma: a radiotherapeutic experience. Int J Radiat Oncol Biol Phys. 1976; 1:1099–1105. PMID: 791910.

18. Smitt MC, Donalldson SH. Radiotheraphy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys. 1995; 31:929–934. PMID: 7860408.

19. Esik O, Ikeda H, Mukai K, Kaneko A. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphoma. Radiother Oncol. 1996; 38:13–18. PMID: 8850421.

20. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored Working Group. J Clin Oncol. 1999; 17:1244. PMID: 10561185.

21. Nango K, Furumura T, Uyama M. Histopathological analysis of 53 cases of orbital tumors. Folia Ophthamol Jpn. 1992; 42:1271–1278.

22. Hiroshi T, Kazuhito T, Hidetoshi Y. Diagnosis and treatment of orbital malignant lymphoma: 14-year review at Yamagata university. Jpn J Ophthalmol. 2001; 45:305–312. PMID: 11369383.

23. Medeiros LJ, Harris NL. Lymphoid infiltrates of the orbit and conjunctiva: a morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol. 1989; 13:459–471. PMID: 2658631.

24. Knowles DM, Jakobiec FA, McNally L, Bruke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990; 21:959–973. PMID: 2394438.

25. Jo YJ, Yim JH, Park KS. MALT (mucosa associated lymphoid tissue) type lymphoma of the ocular adnexa. J Korean Ophthalmol Soc. 2002; 43:357–362.

26. Kim SS, Ahn SD, Chang HS, et al. Primary orbital lymphoma: A retrospective analysis of result of radiation therapy. J Korean Soc Ther Radiol Oncol. 2002; 20:139–146.

27. Cho EY, Han JJ, Ree HJ, et al. Clinicopathologic Analysis of ocular adnexal lymphomas: Extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol. 2003; 73:87–96. PMID: 12749009.

28. Lee JL, Kim MK, Lee KH, et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissuetype of the orbit and ocular adnexa. Ann Hematol. 2005; 84:13–18. PMID: 15309523.

29. Lauer SA. Ocular adnexal lymphoid tumors. Curr Opin Ophthalmol. 2000; 11:361–366. PMID: 11148704.

30. Hornblass A, Jakobiek FA, Reifler DM, Mines J. Orbital lymphoid tumor located predominantly within extraocular muscles. Ophthalmology. 1987; 94:688–697. PMID: 3627718.

31. Galieni P, Polito E, Leccisotti A, et al. Localized orbital lymphoma. Haematologica. 1997; 82:436–439. PMID: 9299857.

32. Hauke RJ, Armitage JO. A new approach to non-Hodgkin's lymphoma. Intern Med. 2000; 39:197. PMID: 10772120.

33. de Jong D, Aleman BMP, Taal BG, et al. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol. 1999; 10:275–280. PMID: 10355570.

34. Byon DS, Moon YS, Kim JS, Kwak HJ. Histological progress observation of conjunctival MALToma. J Korean Ophthalmol Soc. 2002; 43:443–448.

35. Surbone A, Longo DL, DeVita VT Jr, et al. Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management. J Clin Oncol. 1988; 6:1832–1837. PMID: 3199167.

36. Coiffier B, Lepage E. Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen. Blood. 1989; 74:558–564. PMID: 2752133.